These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15190298)

  • 21. Overview of clinical PET.
    Maisey MN
    Br J Radiol; 2002 Nov; 75 Spec No():S1-5. PubMed ID: 12523320
    [No Abstract]   [Full Text] [Related]  

  • 22. Pretransplant positive positron emission tomography/gallium scans predict poor outcome in patients with recurrent/refractory Hodgkin lymphoma.
    Jabbour E; Hosing C; Ayers G; Nunez R; Anderlini P; Pro B; Khouri I; Younes A; Hagemeister F; Kwak L; Fayad L
    Cancer; 2007 Jun; 109(12):2481-9. PubMed ID: 17497648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma.
    Schneider DB; Clary-Macy C; Challa S; Sasse KC; Merrick SH; Hawkins R; Caputo G; Jablons D
    J Thorac Cardiovasc Surg; 2000 Jul; 120(1):128-33. PubMed ID: 10884665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Using isotopes with short half-life in the diagnostics of oncological diseases].
    Minn H; Kööbi T; Ahonen A
    Duodecim; 2003; 119(1):26-32. PubMed ID: 12607469
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical PET in oncology.
    Biersack HJ; Bender H; Ruhlmann J; Oehr P; Guhlke S; Grünwald F
    Rev Esp Med Nucl; 2000 Jun; 19(3):219-24. PubMed ID: 11062087
    [No Abstract]   [Full Text] [Related]  

  • 26. 18-Fluorodeoxyglucose positron emission tomography (FDG-PET) and the staging of early lung cancer.
    Laking G; Price P
    Thorax; 2001 Sep; 56 Suppl 2(Suppl 2):ii38-44. PubMed ID: 11514705
    [No Abstract]   [Full Text] [Related]  

  • 27. [Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
    Comans EF; Hoekstra OS; Hoekman K; van der Hoeven JJ; Golding RP; Teule GJ
    Ned Tijdschr Geneeskd; 2000 Aug; 144(32):1520-8. PubMed ID: 10949634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.
    Hofman MS; Fields P; Yung L; Mikhaeel NG; Ireland R; Nunan T
    Br J Haematol; 2007 Jun; 137(5):386. PubMed ID: 17355259
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical role of FDG PET in evaluation of cancer patients.
    Kostakoglu L; Agress H; Goldsmith SJ
    Radiographics; 2003; 23(2):315-40; quiz 533. PubMed ID: 12640150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.
    Dooms C; Verbeken E; Stroobants S; Nackaerts K; De Leyn P; Vansteenkiste J
    J Clin Oncol; 2008 Mar; 26(7):1128-34. PubMed ID: 18309948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma.
    Leleu X; Fouquet G; Hebraud B; Roussel M; Caillot D; Chrétien ML; Arnulf B; Szalat R; Garderet L; Benajiba L; Pegourie B; Regny C; Royer B; Caulier A; Stoppa AM; Garciaz S; Touzeau C; Chaleteix C; Fermand JP; Loiseau HA; Facon T; Attal M; Moreau P;
    Leukemia; 2013 Nov; 27(11):2242-4. PubMed ID: 23558525
    [No Abstract]   [Full Text] [Related]  

  • 32. Chemotherapy-induced pericarditis on F-18 FDG positron emission tomography scan.
    Losik SB; Studentsova Y; Margouleff D
    Clin Nucl Med; 2003 Nov; 28(11):913-5. PubMed ID: 14578708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.
    Kauppi JT; Oksala N; Salo JA; Helin H; Karhumäki L; Kemppainen J; Sihvo EI; Räsänen JV
    Acta Oncol; 2012 May; 51(5):636-44. PubMed ID: 22208782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Early prediction of treatment response to high-dose chemotherapy in patients with relapsed germ cell tumors using [18F]FDG-PET, CT or MRI, and tumor marker].
    Pfannenberg AC; Oechsle K; Kollmannsberger C; Dohmen BM; Bokemeyer C; Bares R; Vontheim R; Claussen CD
    Rofo; 2004 Jan; 176(1):76-84. PubMed ID: 14712410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Indications of PET imaging].
    Lomeña Caballero FJ; Simó Perdigó M
    Med Clin (Barc); 2003 May; 120(19):742-9. PubMed ID: 12781085
    [No Abstract]   [Full Text] [Related]  

  • 36. F-18 FDG PET: mottled splenomegaly with remission of symptoms after splenectomy in sarcoidosis.
    Vento JA; Arici M; Spencer RP; Sood R
    Clin Nucl Med; 2004 Feb; 29(2):103-4. PubMed ID: 14734908
    [No Abstract]   [Full Text] [Related]  

  • 37.
    Prigent K; Aide N
    PET Clin; 2020 Jan; 15(1):1-10. PubMed ID: 31735296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET scanning in malignancy: infant, adolescent or mature citizen?
    Brennan MF
    Ann Surg; 2001 Mar; 233(3):320-1. PubMed ID: 11224618
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of 18FDG-positron emission tomography scanning in the management of histiocytosis.
    Blum R; Seymour JF; Hicks RJ
    Leuk Lymphoma; 2002 Nov; 43(11):2155-7. PubMed ID: 12533041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HCFA approves Medicare coverage of PET scans.
    Cave L
    J Natl Cancer Inst; 2001 Feb; 93(3):177. PubMed ID: 11158185
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.